United States Uterine Fibroid Market MRFR Unleashes the Forecast for 2018 – 2023

 

Market Overview

Uterine fibroids are the noncancerous growths of the uterus, which mostly appear during childbearing years. It is the abnormal growth of that gets developed inside or on the wall of a woman’s uterus. Uterine fibroids is also known as myomas or leiomyomas. The symptom of uterine fibroids are frequent urination, constipation, backache, heavy menstrual bleeding, pelvic pressure, or menstrual periods lasting more than a week. The women with mild symptoms may go for medical treatments such as hormonal drugs, gonadotropin agonists, progestin and oral contraceptives. Women with moderate to severe symptoms may need surgery to treat uterine fibroids. According to the U.S. Department of Health and Human Services office on Women Health, about 20% to 80% of women develop fibroids by the age of 50 and nearly 30% will get them at the age of 35. Uterine fibroids are most common in women in their 40s and early 50s.

The United States Uterine Fibroid market is showing the significant growth; mainly due to change in lifestyle mainly dietary pattern, growing number of hysterectomy surgeries. Additionally rising in aging population also leads the Uterine Fibroid market with in this region.

United States Uterine Fibroid Market Drivers:

AstraZeneca (U.K), Cook Medical Inc. (U.S.), Boston Scientific Corporation (U.S.), GE Healthcare (U.K), AbbVie Inc. (U.S.), Hologic (U.S.), CooperSurgical Inc. (U.S.), C. R. Bard, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and Bayer AG (Germany) are some of the leading players at the cutting edge of the competition in the market of Uterine Fibroid.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/uterine-fibroid-market-2394  

United States Uterine Fibroid Market   - Regional Analysis

The market of Uterine Fibroid devices is much higher in the United States region, owing to its high prevalence in African- American race, change in lifestyle. According to one large cohort study of NIS on African-American women in Maryland, uterine fibroids was the cause of 65.4% of total 53,000 women undergoing hysterectomy.

Moreover, most of the major market players belong from this region, thus they introduce the advance technology firstly in the United States in comparison to others region.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Popular posts from this blog

Global Storage Tanks Market Sale Area and Revenue Analysis, Comprehensive Study Covid-19 Impact Analysis till 2026

Aluminum Cladding Panel Market Top Manufacturers Growth Insights and Future Outlook by IDA

Hydrogen Fluoride Market Rising Trends, Technology Advancements and In-depth Research Future Analysis